WallStreetZenWallStreetZen

NASDAQ: FBRX
Forte Biosciences Inc Earnings & Revenue

OverviewEarnings
DividendOwnership

FBRX past revenue growth

How has FBRX's revenue growth performed historically?
Company
N/A
Industry
58.31%
Market
17.32%
FBRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FBRX's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

FBRX earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$12.3M
Current Profit Margin
0%

FBRX Return on Equity

Current Company
-30.4%
Current Industry
-9.8%
Current Market
-9.5%
FBRX's Return on Equity (-30.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when FBRX announces earnings.

FBRX Return on Assets

Current Company
-29.1%
Current Industry
0.6%
FBRX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FBRX Return on Capital Employed

Current Company
-28.82%
Current Industry
11.2%
FBRX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FBRX vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FBRX$0.00-$12.34M-$12.34M-100.00%N/A
BIOR$726.00k-$106.49M-$117.31M-86.06%N/A
NRSN$0.00-$12.21M-$12.34MN/AN/A
BTTX$0.00-$41.10M-$43.70MN/AN/A
AIM$134.00k-$20.62M-$20.90M-19.77%N/A
View Top Biotech Stocks

FBRX earnings dates

Next earnings date
Mar 29, 2023

Forte Biosciences Earnings & Revenue FAQ

What were FBRX's earnings last quarter?

On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q3 2022 earnings per share (EPS) of -$0.18, up 66.67% year over year. Total Forte Biosciences earnings for the quarter were -$3.40 million. In the same quarter last year, Forte Biosciences's earnings per share (EPS) was -$0.54.

If you're new to stock investing, here's how to buy Forte Biosciences stock.

What was FBRX's earnings growth in the past year?

As of Q1 2023, Forte Biosciences's earnings has grown year over year. Forte Biosciences's earnings in the past year totalled -$12.34 million.

What is FBRX's earnings date?

Forte Biosciences's earnings date is Invalid Date. Add FBRX to your watchlist to be reminded of FBRX's next earnings announcement.

What was FBRX's revenue last quarter?

On Invalid Date, Forte Biosciences (NASDAQ: FBRX) reported Q3 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Forte Biosciences's revenue was $0.00.

What was FBRX's revenue growth in the past year?

As of Q1 2023, Forte Biosciences's revenue has grown null year over year. Forte Biosciences's revenue in the past year totalled $0.00.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.